# Puyi Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/puyi-biotechnology

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.puyibio.com
- Latest round: Series A (May 21, 2018)
- Investors on record: 2

## About

Based in Shanghai, China and established in 2012, Puyi Biotechnology is a biotechnology company that engages in the research and development, production and sale of interventional treatment devices. In 2017, The fully degradable sinus drug stent system developed by the company obtained a product registration certificate from the National Food and Drug Administration.

The company's products include sinus drug stent system, nasal septum stent, eustachian tube balloon, olfactory reagent, etc. Besides, the company has also developed cervical balloons, biodegradable ureteral stents, hyaluronic acid and other products in the fields of gynecology, urology, and cosmetic medicine.

In 2021, the company plans to list on the Hong Kong Stock Exchange.

## Funding rounds

- Series A, May 21, 2018 — Legend Capital, NLVC

## Investors

- Legend Capital — Series A
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A